Cargando…

TEMPOL inhibits SARS-CoV-2 replication and development of lung disease in the Syrian hamster model

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide outbreak, known as coronavirus disease 2019 (COVID-19). Alongside vaccines, antiviral therapeutics is an important part of the healthcare response to COVID-19. We previously reported that TEMPOL, a small molecule sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maio, Nunziata, Cherry, Sara, Schultz, David C., Hurst, Brett L., Linehan, W. Marston, Rouault, Tracey A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444323/ https://www.ncbi.nlm.nih.gov/pubmed/36093377 http://dx.doi.org/10.1016/j.isci.2022.105074

Ejemplares similares

SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters
por: Halfmann, Peter J, et al.
Publicado: (2021)

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2020)

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2021)

Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets
por: Maio, Nunziata, et al.
Publicado: (2021)

Targeting HIF2α Translation with Tempol in VHL-Deficient Clear Cell Renal Cell Carcinoma
por: Sourbier, Carole, et al.
Publicado: (2012)

Characterization of Virus Replication, Pathogenesis, and Cytokine Responses in Syrian Hamsters Inoculated with SARS-CoV-2
por: Yang, Shiu-Ju, et al.
Publicado: (2021)

An immunosuppressed Syrian golden hamster model for SARS-CoV infection
por: Schaecher, Scott R., et al.
Publicado: (2008)

Pathogenesis and transmission of SARS-CoV-2 in golden Syrian hamsters
por: Sia, Sin Fun, et al.
Publicado: (2020)

SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract
por: Hansen, Frederick, et al.
Publicado: (2022)

The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters
por: de Wit, Emmie, et al.
Publicado: (2013)

Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters
por: Osterrieder, Nikolaus, et al.
Publicado: (2020)

Valganciclovir Inhibits Human Adenovirus Replication and Pathology in Permissive Immunosuppressed Female and Male Syrian Hamsters
por: Toth, Karoly, et al.
Publicado: (2015)

Experimental Models in Syrian Golden Hamster Replicate Human Acute Pancreatitis
por: Wang, Yunan, et al.
Publicado: (2016)

Dexamethasone ameliorates severe pneumonia but slightly enhances viral replication in the lungs of SARS-CoV-2-infected Syrian hamsters
por: Yuan, Lunzhi, et al.
Publicado: (2022)

Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters
por: Takamatsu, Yuki, et al.
Publicado: (2022)

Bergamottin, a bioactive component of bergamot, inhibits SARS-CoV-2 infection in golden Syrian hamsters
por: Zhou, Minmin, et al.
Publicado: (2022)

Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters
por: Gallardo-Toledo, Eduardo, et al.
Publicado: (2023)

SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
por: Mohandas, Sreelekshmy, et al.
Publicado: (2021)

Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2021)

Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster
por: Port, Julia R., et al.
Publicado: (2023)

Histopathologic Characterization of Experimental Peracute SARS-CoV-2 Infection in the Syrian Hamster
por: Clancy, Chad S., et al.
Publicado: (2023)

LYMPHOCYTIC CHORIOMENINGITIS IN THE SYRIAN HAMSTER
por: Smadel, J. E., et al.
Publicado: (1942)

The Experimental Use of Syrian Hamsters
por: Valentine, Helen, et al.
Publicado: (2012)

The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters
por: Shytaj, Iart Luca, et al.
Publicado: (2022)

Corrigendum: Experimental Models in Syrian Golden Hamster Replicate Human Acute Pancreatitis
por: Wang, Yunan, et al.
Publicado: (2016)

Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters
por: Brocato, Rebecca L., et al.
Publicado: (2020)

SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters
por: Selvaraj, Prabhuanand, et al.
Publicado: (2021)

Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster
por: Yuan, Lunzhi, et al.
Publicado: (2021)

Mucociliary Transport Deficiency and Disease Progression in Syrian Hamsters with SARS-CoV-2 Infection
por: Li, Qian, et al.
Publicado: (2022)

SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters
por: Qiao, Wei, et al.
Publicado: (2022)

Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters
por: Field, C. J., et al.
Publicado: (2022)

Detection of SARS-CoV-2 peptide-specific antibodies in Syrian hamster serum by ELISA
por: Quach, Huy Quang, et al.
Publicado: (2022)

Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model
por: Foo, Caroline S., et al.
Publicado: (2022)

Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters With SARS-CoV-2
por: Becker, Kathrin, et al.
Publicado: (2021)

SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters
por: Plunkard, Jessica, et al.
Publicado: (2023)

Mucociliary transport deficiency and disease progression in Syrian hamsters with SARS-CoV-2 infection
por: Li, Qian, et al.
Publicado: (2023)

Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model
por: Chiba, Shiho, et al.
Publicado: (2022)

Aflatoxin induced lesions in Syrian hamsters.
por: Herrold, K. M.
Publicado: (1969)

Detection of natural cytotoxicity in Syrian hamsters.
por: Rees, R. C., et al.
Publicado: (1980)

Generation of transgenic golden Syrian hamsters
por: Gao, Mingming, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8vt7tntq8n7v1m3ue8upr29atk